You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 醫藥商業概念股逆勢走強 藥品管理法經全國人大常委會表決通過
格隆匯 08-26 15:15
格隆匯8月26日丨醫藥商業概念股逆勢走強,截至收盤,國藥一致(000028.SZ)漲停,重藥控股(000950.SZ)接近漲停。今日上午,新修訂的《中華人民共和國藥品管理法》經十三屆全國人大常委會第十二次會議表決通過,將於2019年12月1日起施行。針對羣眾反映強烈的假藥、劣藥、藥價高、藥品短缺等突出問題,新修訂的藥品管理法體現了最嚴謹的標準、最嚴格的監管、最嚴厲的處罰、最嚴肅的問責“四個最嚴”精神,進一步健全了覆蓋藥品研製、生產、經營、使用全過程的法律制度。渤海證券最近發佈研報,在醫藥商業方面,推薦工商一體化的上海醫藥以及估值成長匹配的一心堂、國藥一致。中信證券近日也發佈研報指出,維持連鎖藥店行業“強於大市”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account